Glipizide is an oral rapid- and short-acting anti-diabetic drug from the sulfonylurea class. It is classified as a second generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas.

CAS：29094-61-9
中文别名：格列甲嗪;
英文别名：Ozidia;exylurea;N-[4-(3-Cyclohexylureidosulfonyl)phenethyl]-5-methyl-2-pyrazinecarboxamide;1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea;Digrin;k4024;tk1320;Glipizide;Melizide;Aldiab;Glipid;Glidiab;Glican;
分子式：C21H27N5O4S
分子量：445.535
精确质量：445.178
Psa：138.53
Logp：4.3316

MDL号：MFCD00072159

外观与性状：白色或灰白色结晶粉末
密度：1.34 g/cm3
熔点：208-209°C
折射率：1.597
储存条件：Store in a tightly closed container. Store in a dry area. Store at around 20ºC.

RTECS号：YS7640000
安全说明：S24/25
危险类别码：R21
WGK Germany：3
海关编码：2935009090
危险品标志：Xi; Xn

用途
为非胰岛素依赖型（Ⅱ）型糖尿病之降糖良药，本品主要用于单用饮食控制治疗未能达到良好效果的轻、中度非胰岛素依赖型病人。